Parkinson's Pharmacotherapy: Difference between revisions
(Created page with " == Introduction == == Epidemiology of Parkinson's Disease == == Levodopa in the treatment of Parkinson's Disease == == Anticholinergic Drugs in the treatment of Parkin...") |
No edit summary |
||
| Line 4: | Line 4: | ||
== [[Epidemiology of Parkinson's Disease]] == | == [[Epidemiology of Parkinson's Disease]] == | ||
== Levodopa in the treatment of Parkinson's Disease == | == [[Levodopa in the treatment of Parkinson's Disease]] == | ||
== Anticholinergic Drugs in the treatment of Parkinson's Disease == | == [[Anticholinergic Drugs in the treatment of Parkinson's Disease]] == | ||
== MAO-B inhibitors in the treatment of Parkinson's Disease == | == [[MAO-B inhibitors in the treatment of Parkinson's Disease]] == | ||
== Dopamine Agonist Drugs in the treatment of Parkinson's Disease == | == [[Dopamine Agonist Drugs in the treatment of Parkinson's Disease]] == | ||
== Physical Therapy Implications for Parkinson's Disease Drugs == | == [[Physical Therapy Implications for Parkinson's Disease Drugs]] == | ||
== Conclusion == | == Conclusion == | ||
